AMSC And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – AMSC (AMSC.OL), SPBK 1 ØSTLANDET (SPOL.OL), ITERA (ITERA.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. AMSC (AMSC.OL)

1395% sales growth and 8.21% return on equity

AMSC ASA, through its subsidiaries, operates as a ship owning and lease finance company in the United States. The company purchases and bareboat charters out vessels to operators and end users. It operates a fleet of nine product tankers, one shuttle tanker, and one subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was founded in 2005 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, AMSC has a trailing twelve months EPS of kr2.05.

PE Ratio

AMSC has a trailing twelve months price to earnings ratio of 21.8. Meaning, the purchaser of the share is investing kr21.8 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.

Volume

Today’s last reported volume for AMSC is 61537 which is 15.48% below its average volume of 72810.

More news about AMSC.

2. SPBK 1 ØSTLANDET (SPOL.OL)

20.3% sales growth and 11.87% return on equity

SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. SpareBank 1 Østlandet operates as a subsidiary of Sparebankstiftelsen Hedmark.

Earnings Per Share

As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr13.36.

PE Ratio

SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 10.01. Meaning, the purchaser of the share is investing kr10.01 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.87%.

More news about SPBK 1 ØSTLANDET.

3. ITERA (ITERA.OL)

12.4% sales growth and 97.07% return on equity

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.79.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 15.19. Meaning, the purchaser of the share is investing kr15.19 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 97.07%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 831.86M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ITERA’s EBITDA is 41.68.

More news about ITERA.

4. MELEXIS (MELE.BR)

11% sales growth and 43.81% return on equity

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

Earnings Per Share

As for profitability, MELEXIS has a trailing twelve months EPS of €5.04.

PE Ratio

MELEXIS has a trailing twelve months price to earnings ratio of 16.76. Meaning, the purchaser of the share is investing €16.76 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.81%.

More news about MELEXIS.

5. MULTICONSULT (MULTI.OL)

10% sales growth and 34.44% return on equity

Multiconsult ASA provides engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy, design, planning, project supervision and management, geotechnical site survey, verification and control, analysis and due diligence, construction management, geological investigations, environmental services and HSE, river basin management, hydrometry, and hydrological field work services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. Multiconsult ASA was founded in 1908 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, MULTICONSULT has a trailing twelve months EPS of kr11.41.

PE Ratio

MULTICONSULT has a trailing twelve months price to earnings ratio of 11.88. Meaning, the purchaser of the share is investing kr11.88 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.44%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10%, now sitting on 4.47B for the twelve trailing months.

Yearly Top and Bottom Value

MULTICONSULT’s stock is valued at kr135.50 at 02:20 EST, way below its 52-week high of kr169.00 and way higher than its 52-week low of kr114.80.

More news about MULTICONSULT.

6. SPAREBANKEN MØRE (MORG.OL)

6% sales growth and 11.3% return on equity

Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.

Earnings Per Share

As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr16.2.

PE Ratio

SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 4.87. Meaning, the purchaser of the share is investing kr4.87 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.3%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 33.2%, now sitting on 1.98B for the twelve trailing months.

Yearly Top and Bottom Value

SPAREBANKEN MØRE’s stock is valued at kr78.85 at 02:20 EST, way below its 52-week high of kr88.88 and way higher than its 52-week low of kr67.98.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 5.13%.

More news about SPAREBANKEN MØRE.

7. MEDISTIM (MEDI.OL)

5.8% sales growth and 34.9% return on equity

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.18.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 31.39. Meaning, the purchaser of the share is investing kr31.39 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.9%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 2.13%.

More news about MEDISTIM.

Leave a Reply

Your email address will not be published. Required fields are marked *